Preeclampsia is one of those pregnancy complications that every expecting parent hopes to avoid. It develops after 20 weeks of pregnancy and involves dangerously high blood pressure that can damage the kidneys, liver, and other organs. In severe cases, it can progress to eclampsia (seizures) and threatens both the parent's and baby's life.
What's been getting our attention in the research world is a growing body of evidence linking PFAS exposure to increased preeclampsia risk. We want to walk you through what the science actually shows - no fear-mongering, just the facts parents deserve to know.
What Is Preeclampsia
Preeclampsia affects roughly 5-8% of pregnancies globally and remains a leading cause of maternal and fetal morbidity. It is characterized by new-onset hypertension (blood pressure at or above 140/90 mmHg) combined with proteinuria (protein in urine) or other signs of organ dysfunction developing after 20 weeks of gestation.
Risk factors include first pregnancy, pre-existing hypertension, obesity, diabetes, kidney disease, and family history. But researchers have been investigating environmental chemical exposures as additional contributors - and PFAS have emerged as a significant area of concern.
The condition requires careful monitoring and sometimes early delivery. Severe preeclampsia can lead to HELLP syndrome, placental abruption, stroke, and organ failure. It is also associated with long-term cardiovascular risk for the birthing parent and adverse outcomes for the baby, including preterm birth and low birth weight.
The Research Connecting PFAS to Preeclampsia
The link between PFAS and preeclampsia has been investigated across multiple countries and populations, and the pattern is consistent enough to warrant serious attention.